Organic Process Research & Development · 2004 · 19 citations · 2 references
PharmacyMedicinal ChemistryPharmaceutical AnalysisAnalytical ChemistryPharmaceutical ManufacturingPharmaceutical TechnologyAnalytical Method ValidationDrug Safety MonitoringDrug Substance ManufacturingPhysicochemical CharacterizationProcess Analytical ChemistryIn-line Process MonitoringOxidationProcess Analytical MonitoringProcess Analytical TechnologyProcess-related Impurity IdentificationProduct Quality MonitoringPurity ControlRecrystallization
The development of a safe and scalable oxidation process for the hydroxylation of the azapirone psychotropic agent buspirone ( 1 ) to furnish 6-hydroxybuspirone ( 2 ) is described. A mechanistic understanding of how key process factors affected product quality led to the successful application of FTIR as a process analytical technology (PAT) tool. This enabled real time quality assurance and the development of an effective and efficient manufacturing process. The identification of impurities and the development of recrystallization methods to provide active pharmaceutical ingredients (API) with optimal purity will also be addressed.
2
E. Bailey, D. H. R. Barton, J. Elks et al. · Journal of the Chemical Society (Resumed) · 1962 · 108 citations